Pfizer’s Centrum Will No Longer Claim It Aids “Breast Health” and “Colon Health”

As reported by Reuters (here) "Pfizer, bowing to allegations of deceptive advertising lodged by a consumer watchdog group, has agreed to drop 'breast health' and 'colon health' claims from the labels...

Merck on a Roll

Merck is on a roll these days.For one thing, it's stock price has almost recovered from its low point after Vioxx was withdrawn from the market:Who among us -- who did...

Lily-White Lilly. Homophobic and Sexist Too?

According to a recent Indy Star story, "dozens of current and former workers at Eli Lilly and Co. are stepping forward to accuse the Indianapolis drug maker of racial discrimination, adding...

DJIA Crash Dummy!

The auto industry is using the DJIA as a crash dummy!The stock market is down again today.

Ad Execs Not Viewed as Innovative By Americans Says AstraZeneca Survey

Sorry to break this to you, but Americans don't think advertising executives are very innovative. This is according to the AstraZeneca Innovation Survey (find it here). "By carrying out this survey...

It’s a bird…it’s a plane…it’s PharmExec 50, but what’s that molecule?

The May 2009 issue of Pharmaceutical Executive (PE) Magazine is here. It's cover features a 3-D image of a super hero ("50 Man") holding a complex molecule as he flies above...

Celebrex Joins the bAdWord Bandwagon!

Just when I thought it was safe to stop raking Pfizer over the coals about torcetrapib, they go and do something stupid! I'm talking about running a Google Adword program that...

Graduation Day at Roche Digital Academy: What’s Next?

The Roche Digital Academy concluded with a Graduation day on July 1. This training program, developed by the Digital Team Roche Italy, in collaboration with the School of Communication and...

New Year’s Resolutions for Pharma Marketers

My #1 New Year's Resolution is to stop telling pharmaceutical marketers what to do all the time.Now, here's my list of resolutions for pharma marketers:1. Don't Start a Blog and Then...

My Bad! Paula Dean Shills for Novo Nordisk, Not Novartis

Last week I reported on a story that celebrity southern-style chef Paula Deen has type 2 diabetes and that she is a spokesperson for Novartis's diabetes franchise (see "Sanofi vs Novartis:...

Pharma Marketing News, Blog Posts, Events, Podcasts

- Advertisement -